Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Polydex Pharmaceuticals Ltd. (POLXF) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal year, ending 2023-01-31.
| Income Statement Financials | |
$4.40M |
|
$-0.77M |
|
$4.19M |
|
$0.21M |
|
$5.17M |
|
$-0.76M |
|
-- |
|
$-0.76M |
|
$-0.76M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.73M |
|
$-0.40M |
|
3.43M |
|
3.43M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$2.52M |
|
$2.94M |
|
$3.45M |
|
$5.97M |
|
$0.79M |
|
$0.00M |
|
$0.10M |
|
$0.88M |
|
$5.07M |
|
$5.09M |
|
$5.09M |
|
3.43M |
|
| Cash Flow Statement Financials | |
$-0.85M |
|
$0.20M |
|
$-0.18M |
|
$1.03M |
|
$0.30M |
|
$-0.73M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.20 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
4.80% |
|
-17.35% |
|
-16.61% |
|
-9.16% |
|
-17.35% |
|
-17.40% |
|
$-1.02M |
|
-- |
|
-- |
|
-- |
|
0.74 |
|
3.46 |
|
5.44 |
|
67.04 |
|
-15.11% |
|
-15.07% |
|
-12.84% |
|
-15.06% |
|
$1.48 |
|
$-0.30 |
|
$-0.25 |
|